HTUPA as a new thrombolytic agent for acute myocardial infarction: a multicenter, randomized study.

@article{Sun2014HTUPAAA,
  title={HTUPA as a new thrombolytic agent for acute myocardial infarction: a multicenter, randomized study.},
  author={Yingxian Sun and Xingli Liu and Liang Guo and Wenyue Pang and Xiaofan Guo and Zhaoqing Sun and Zhanquan Li and Xiaoying Cui and Hui Li and Guizhou Tao and Lanfeng Wang and Changyong Zhou and Ying Yu Liu and Hongwei Shan and Manqing Wang and Mingxin Liu and Jia Li and Lei Yin and Da-yi Hu},
  journal={International journal of cardiology},
  year={2014},
  volume={172 2},
  pages={326-31}
}
BACKGROUND It is necessary to develop a new thrombolytic agent which can be used by a single bolus at first aid sites to decrease the time to reperfusion in clinical practice. HTUPA, a genetically engineered new thrombolytic with a longer half-life, is well qualified. We aim to compare the thrombolytic efficacy and safety of human tissue urokinase type… CONTINUE READING